Last reviewed · How we verify
NCT06324799
The Effect of Position Change Frequency on Hyperbilirubinemia
NA trial testing phototherapy treatment in Newborn; Vitality in 64 participants. Completed in 24 March 2025.
14 September 2024
Quick facts
| Lead sponsor | Tarsus University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 64 |
| Start date | 14 March 2024 |
| Primary completion | 14 September 2024 |
| Estimated completion | 24 March 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- phototherapy treatment
Conditions studied
- Newborn; Vitality — all drugs for Newborn; Vitality →
- Hyperbilirubinemia, Neonatal — all drugs for Hyperbilirubinemia, Neonatal →
Sponsor
Tarsus University
Who can join
Adults 1 Day to 15 Days, any sex, with Newborn; Vitality or Hyperbilirubinemia, Neonatal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In our study, the effect of the frequency of position changes on hyperbilirubinemia in babies hospitalized in the Neonatal Intensive Care Unit and receiving phototherapy treatment will be investigated. This study was planned as a single-center randomized controlled clinical trial to examine the effect of the frequency of position changes on the time it takes for hyperbilirubinemia to subside in babies receiving phototherapy treatment in the Neonatal Intensive Care Unit of Mersin City Training and Research Hospital. Babies included in the study will be randomly divided into two groups by randomization method. While the babies in the study group will be subjected to position changes (supine, prone, lateral) every 2 hours, the same procedure will be applied to the control group every 6 hours. All newborns included in the study were treated with the Unitest (Blue angel) LED Phototherapy device, which is used as standard in the neonatal intensive care unit, at a distance of 25-40 cm, at a wavelength of 425-475 nm, at 45 watts, at 50/60 Hz. Phototherapy will be applied unidirectionally. During phototherapy, only the perineal area of the babies will be covered with a reduced diaper, and their eyes will be covered with a three-layer, cotton, black eye patch that transmits 99.5% of ultraviolet rays. During phototherapy sessions, the total serum bilirubin level of the patient is checked; Phototherapy will be continued until it falls below the threshold value in the Bhutani nomogram, which is evaluated according to postnatal days and risk factors. The descriptive characteristics of the babies included in the study and their total bilirubin and hematocrit values before the start of phototherapy will be recorded on the form prepared by the researchers. After phototherapy begins, position changes will be made every two hours for babies in the experimental group and every six hours for babies in the control group until the total serum bilirubin value falls below the phototherapy threshold value in the Bhutani nomogram. Bilirubin levels will be measured and recorded by venous measurement at the sixth hour and the 24th hour, and this process will be continued regularly until the bilirubin value decreases to the normal range. This practice is performed routinely in the clinic and will not be considered specific to the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06324799
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Newborn; Vitality
Currently open trials in the same condition.
- NCT06693817 — Advanced Wireless Sensors for Neonatal Care in the Delivery Room · NA · recruiting
- NCT06706115 — Effect of Intranasal Breast Milk Administration in Preterm Infants · NA · recruiting
- NCT06279169 — The Effect of Heart Sound and White Noise on Pain and Physiological Parameters During Hepatitis B Vaccine Injection · NA · recruiting
- NCT06332521 — Infant Crying, a Bioacoustic Prognostic Signal for Neurodevelopment · recruiting
Other Tarsus University trials
Trials by the same sponsor.
- NCT07457086 — The Effects of the 4-7-8 Breathing Technique on Sleep Quality, Pain, and Recovery Outcomes in Patients Undergoing Transu · NA · not yet recruiting
- NCT07462390 — Effect of Intrarectal Ice Application on Pain, Anxiety, Cortisol Levels, Development of Complications, and Hospital Read · NA · withdrawn
- NCT07428421 — The Effect of Supporting the Incision Site With Toys During Mobilization in Children Aged 4-10 Years Undergoing Abdomina · NA · recruiting
- NCT07428408 — The Effect of the Side Kangaroo Position in Newborns Undergoing Noninvasive Mechanical Ventilation · NA · not yet recruiting
- NCT07408921 — Effect of Ice Pack and Warm Gel Pad Use During Drain Removal on Anxiety, Comfort, Physiological Parameters, and Patient · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06324799 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tarsus University
- Last refreshed: 15 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06324799.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing